/ULGX
ULGX Stock - Urologix, Inc.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ULGX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-80.29
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|
| Revenue | $14.23M | $16.59M | $17.03M | $12.57M | $14.77M |
| Gross Profit | $6.09M | $8.18M | $8.38M | $6.54M | $8.20M |
| Gross Margin | 42.8% | 49.3% | 49.2% | 52.0% | 55.5% |
| Operating Income | $-6,930,000 | $-3,922,000 | $-4,145,000 | $-3,726,000 | $-2,257,000 |
| Net Income | $-7,608,000 | $-4,292,000 | $-4,695,000 | $-3,733,000 | $-2,169,000 |
| Net Margin | -53.4% | -25.9% | -27.6% | -29.7% | -14.7% |
| EPS | $-0.36 | $-0.21 | $-0.32 | $-0.26 | $-0.15 |
Company Overview
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ULGXBeat Rate
29%
Last 7 quarters
Avg Surprise
-2.3%
EPS vs Estimate
Beats / Misses
2/3
2 met exactly
Latest EPS
$-0.02
Q2 2015
EPS Surprise History
Q3 13
No data
Q4 13
No data
Q1 14
No data
Q2 14
No data
Q3 14
No data
Q4 14
No data
Q1 15
No data
Q2 15
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2015 | May 12, 2015 | — | $-0.02 | — | — |
Q1 2015 | Feb 5, 2015 | — | $-0.02 | — | — |
Q4 2014 | Nov 4, 2014 | — | $-0.02 | — | — |
Q3 2014 | Aug 19, 2014 | — | $-0.17 | — | — |
Q2 2014 | May 6, 2014 | — | $-0.08 | — | — |
Q1 2014 | Feb 4, 2014 | — | $-0.05 | — | — |
Q4 2013 | Oct 29, 2013 | — | $-0.06 | — | — |
Q3 2013 | Aug 20, 2013 | — | $-0.05 | — | — |
Q2 2013 | May 1, 2013 | $-0.06 | $-0.06 | 0.0% | = MET |
Q1 2013 | Feb 5, 2013 | $-0.05 | $-0.06 | -20.0% | ✗ MISS |
Q4 2012 | Nov 14, 2012 | $-0.06 | $-0.05 | +16.7% | ✓ BEAT |
Q3 2012 | Aug 23, 2012 | — | $-0.08 | — | — |
Q1 2012 | Mar 31, 2012 | — | $-0.07 | — | — |
Q4 2011 | Dec 31, 2011 | — | $-0.08 | — | — |
Q3 2011 | Sep 30, 2011 | — | $-0.09 | — | — |
Q2 2011 | Jun 30, 2011 | — | $-0.09 | — | — |
Q2 2011 | Apr 26, 2011 | $-0.06 | $-0.07 | -16.7% | ✗ MISS |
Q1 2011 | Jan 25, 2011 | $-0.05 | $-0.05 | 0.0% | = MET |
Q4 2010 | Nov 3, 2010 | $-0.08 | $-0.05 | +37.5% | ✓ BEAT |
Q3 2010 | Aug 24, 2010 | $-0.03 | $-0.04 | -33.3% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about ULGX
What is ULGX's current stock price?
Urologix, Inc. (ULGX) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ULGX?
No analyst price targets are currently available for this stock.
What sector is Urologix, Inc. in?
Urologix, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is ULGX's market cap?
Urologix, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ULGX pay dividends?
No, Urologix, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANTH
Anthera Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
CANQF
CanaQuest Medical Corp.
$0.00
Mkt Cap: $0.0B
COTQF
Cotinga Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
ETAOF
ETAO International Co., Ltd.
$0.00
Mkt Cap: $0.0B
LPTI
Longport, Inc.
$0.00
Mkt Cap: $0.0B
NEWG
Greenwind Holdings Inc.
$0.00
Mkt Cap: $0.0B
PZRXQ
PhaseRx, Inc.
$0.00
Mkt Cap: $0.0B
SVSO
SheerVision, Inc.
$0.00
Mkt Cap: $0.0B
SYUP
Anbc, Inc.
$0.00
Mkt Cap: $0.0B
THMO
ThermoGenesis Holdings, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to ULGX for comparison